Fennec Pharmaceuticals (NASDAQ:FENC) Stock, Earnings Estimates, EPS, And Revenue

Fennec Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 20
EPS Estimate
$-0.130
Quarterly Revenue Estimate
$16.42M
Annual Revenue
(as of Sep 30)
$49.35M

Analyze the earnings history of Fennec Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Fennec Pharmaceuticals (FENC) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-07$-0.21$-0.10-110.0 %
Q22024-08-13$-0.20$-0.03-566.7 %
Q12024-05-14$0.41$0.2657.7 %
Q42024-03-21$-0.10$-0.02-400.0 %

Fennec Pharmaceuticals (FENC) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-07$6.97M$8.82M-20.9 %
Q22024-08-13$7.26M$11.05M-34.3 %
Q12024-05-14$25.38M$18.88M34.4 %
Q42024-03-21$9.74M$8.67M12.3 %

FAQ

Q

When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?

A

Fennec Pharmaceuticals (FENC) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Fennec Pharmaceuticals (NASDAQ:FENC)?

A

The Actual EPS was $-0.21, which missed the estimate of $-0.10.

Q

What were Fennec Pharmaceuticals’s (NASDAQ:FENC) revenues?

A

The Actual Revenue was $7M, which missed the estimate of $8.8M.

Browse earnings estimates, EPS, and revenue on all stocks.